Selective Nodal Irradiation on Basis of 18FDG-PET Scans in Limited-Disease Small-Cell Lung Cancer: A Prospective Study

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 329-336

  van Loon, Judith ^a   De Ruysscher, Dirk ^a   Wanders, Rinus ^a   Boersma, Liesbeth ^a   Simons, Jean ^b   Oellers, Michel ^a   Dingemans, Anne Marie C ^c   Hochstenbag, Monique ^c   Bootsma, Gerben ^d   Geraedts, Wiel ^d   Pitz, Cordula ^e   Teule, Jaap ^c   Rhami, Ali ^d   Thimister, Willy ^d   Snoep, Gabriel ^c   Dehing Oberije, Cary ^a   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b St Jans Hospital   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Zuyderland Medical Centre   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

Author keywords

combined modality treatment; elective nodal irradiation; PET; positron emission tomography; Selective nodal irradiation; small cell lung cancer

Indexed keywords

ACUTE ESOPHAGITIS; ADVERSE EVENTS; CARBOPLATIN; COMBINED MODALITY TREATMENT; COMMON TERMINOLOGY CRITERIA; COMPUTED TOMOGRAPHY SCAN; CONFIDENCE INTERVAL; DATA SUPPORT; ELECTIVE NODAL IRRADIATION; ESOPHAGITIS; ETOPOSIDE; FDG-PET; LOW RATES; LYMPH NODE; OVERALL SURVIVAL; PET; PET SCAN; PRE-TREATMENT; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; REGIONAL FAILURES; SMALL CELL LUNG CANCERS; SMALL-CELL LUNG CANCER; TWICE-DAILY FRACTIONS;

BIOLOGICAL ORGANS; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DRUG PRODUCTS; IRRADIATION; POSITRONS; RADIATION; RADIOTHERAPY;

POSITRON EMISSION TOMOGRAPHY;

CARBOPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE FREE SURVIVAL; DYSPNEA; ESOPHAGITIS; FEMALE; HUMAN; LUNG SMALL CELL CANCER; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; SURVIVAL TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; MALE; MEDIASTINUM; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SMALL CELL LUNG CARCINOMA; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951865740     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.075     Document Type: Article

References (37)

1. Turrisi III A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340 (1999) 265-271
2. Choi N.C., Herndon II J.E., Rosenman J., et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 16 (1998) 3528-3536
3. De Ruysscher D., Pijls-Johannesma M., Vansteenkiste J., et al. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 17 (2006) 543-552
4. Pijls-Johannesma M.C., De Ruysscher D., Lambin P., et al. Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev (2005) CD004700
5. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
6. De Ruysscher D., Wanders S., van Haren E., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62 (2005) 988-994
7. Senan S., Burgers S., Samson M.J., et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 999-1006
8. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., et al. The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
9. De Ruysscher D., Wanders S., Minken A., et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study. Radiother Oncol 77 (2005) 5-10
10. Baas P., Belderbos J.S., Senan S., et al. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: A Dutch multicenter phase II study. Br J Cancer 94 (2006) 625-630
11. Videtic G.M., Belderbos J.S., Spring Kong F.M., et al. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: Small-cell lung cancer (SCLC). Int J Radiat Oncol Biol Phys 72 (2008) 327-334
12. De Ruysscher D., Bremer R.H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial. Radiother Oncol 80 (2006) 307-312
13. Belderbos J.S., Baas P., and Senan S. Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small cell lung cancer. Br J Cancer 96 (2007) 276
14. Fischer B.M., Mortensen J., Langer S.W., et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: Comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 18 (2007) 338-345
15. Niho S., Fujii H., Murakami K., et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Lung Cancer 57 (2007) 328-333
16. 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer. Anticancer Res 22 (2002) 1257-1264
17. Kamel E.M., Zwahlen D., Wyss M.T., et al. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 44 (2003) 1911-1917
18. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: A planning study. Radiother Oncol 87 (2008) 49-54
19. Grgic A., Nestle U., Schaefer-Schuler A., et al. FDG-PET-based radiotherapy planning in lung cancer: Optimum breathing protocol and patient positioning-An intraindividual comparison. Int J Radiat Oncol Biol Phys 73 (2009) 103-111
20. Nestle U., Kremp S., and Grosu A.L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
21. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16 (1998) 2142-2149
22. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
23. Chapet O., Kong F.M., Quint L.E., et al. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63 (2005) 170-178
24. Senan S., De Ruysscher D., Giraud P., et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
25. Bradley J., Deasy J.O., Bentzen S., et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 1106-1113
26. International Commission on Radiation Units and Measurements. ICRU report 50: Prescribing, recording and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda
27. Green M.R., Cox J.D., Ardizzoni A., et al. Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): A consensus report. Lung Cancer 11 Suppl. 3 (1994) S11-S13
28. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
29. Bradley J.D., Dehdashti F., Mintun M.A., et al. Positron emission tomography in limited-stage small-cell lung cancer: A prospective study. J Clin Oncol 22 (2004) 3248-3254
30. Lenth RV. Java Applets for Power and Sample Size retrieved November, 1, 2006 ed; 2006.
31. Skarlos D.V., Samantas E., Kosmidis P., et al. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer: A Hellenic Co-operative Oncology Group study. Ann Oncol 5 (1994) 601-607
32. De Ruysscher D., Pijls-Johannesma M., Bentzen S.M., et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 24 (2006) 1057-1063
33. De Ruysscher D., Dehing C., Bremer R.H., et al. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18 (2007) 909-916
34. Pandit N., Gonen M., Krug L., et al. Prognostic value of [18F]FDG-PET imaging in small cell lung cancer. Eur J Nucl Med Mol Imaging 30 (2003) 78-84
35. Inoue M., Nakagawa K., Fujiwara K., et al. Results of preoperative mediastinoscopy for small cell lung cancer. Ann Thorac Surg 70 (2000) 1620-1623
36. Sakai M., Ishikawa S., Yamamoto T., et al. Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy. Interact Cardiovasc Thorac Surg 4 (2005) 118-122
37. Shepherd F.A., Ginsberg R.J., Feld R., et al. Surgical treatment for limited small-cell lung cancer: The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg 101 (1991) 385-393